Loading...

VRTX VERTEX PHARMACEUTICALS INC Management Changes 8-K Filing

VRTX

VRTX

VERTEX PHARMACEUTICALS INC

(VRTX)

2026 8-K

Financial Results Update

Board Member Departure

FDA Application Submitted

Financial Results Report

Financial Results Report

Financial Statements

Impairment Charge

Management Changes

Financial Results

Lease Extension

Financial Results Announcement

Annual Meeting Voting Results

Financial Results

Merger Agreement

Financial Results Announcement

FDA Approval and Pricing An...

Appointment of Nancy Thornb...

Financial Results

Appointment of Director

Financial Results

Annual Meeting Voting Results

Financial Results Announcement

External Links:

On April 28, 2026, Suketu Upadhyay informed Vertex Pharmaceuticals he will not seek re-election to the Board at the 2026 Annual Meeting due to conflicts with his new role as CFO of Incyte Corporation; the board size will reduce to ten members afterwards. This change does not indicate any disagreement regarding the company's operations.

AI Assistant

VERTEX PHARMACEUTICALS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.